We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Paula J. Bretz
Paula J. Bretz
Products
PRODUCTS
Mylan Pharmaceuticals, Inc.
Paula J. Bretz
,
Jonathan Chapman
, and
Brooke K. Higgins
Price:
$117.00
View
Afton Scientific Corp.
Paula J. Bretz
and
Brooke K. Higgins
Price:
$117.00
View
Mylan Pharmaceuticals, Inc.
Paula J. Bretz
and
William A. Warnick
Price:
$117.00
View
Upcoming Events
19
May
CDRH’s New Accreditation Scheme for Conformity Assessment: Impacts on Your Future Testing Plans and FDA Submissions
25
May
How Can the Accelerated Availability of Pfizer-BioNTech’s COVID-19 Vaccine be Replicated?
26
May
Biopharmaceutical Supply Chain Issues Before, During and After the Pandemic: Impact on the Pharmaceutical Industry’s Regulatory, Quality and Compliance Professionals
27
May
Evolving Clinical Trials: Continuing the Journey from Paper to Digital
09
Jun
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15
Jun
Create a Quality Culture to Aid Risk Management: Dynamic Behaviors that Achieve Quality and Business Objectives
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
FDA Grants Bold Therapeutics Orphan Drug Status for Gastric Cancer Treatment
bioMérieux Earns CE Mark for COVID-19 Antibody Serology Test
Pfizer’s Rare Heart Disease Drug Vyndaqel Turned Down by NICE
Whiterabbit Earns 510(k) Clearance for Breast Cancer AI Software
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
